Integrated Biopharma Inc's

• INBP's Stock Performance relative to its Competitors

Innoviva Inc Share Performance +7.35% This Year

Innoviva Inc Profile Innoviva Inc's business model revolves around the development and commercialization of pharmaceutical products. The company primarily focuses on creating strategic collaborations and partnerships with biopharmaceutical companies to advance innovative therapies. Innoviva generates revenue through royalty payments received based on the sales of its partnered products. More about Innoviva Inc 's Market Share

Matinas Biopharma Holdings Inc Share Performance -9.00% Over The Past 5 Days

Matinas Biopharma Holdings Inc Profile Matinas Biopharma Holdings Inc operates as a clinical-stage biopharmaceutical company. Their business model centers around developing therapeutics through the utilization of lipid nano-crystal (LNC) platform technologies. These technologies enable the effective delivery of drugs to improve patient outcomes in various diseases and conditions such as fungal infections, viral infections, and cancer. More about Matinas Biopharma Holdings Inc 's Market Share

Nektar Therapeutics Share Performance +25.26% This Quarter

Nektar Therapeutics Profile Nektar Therapeutics operates under a business model focused on developing and commercializing innovative medicines. The company's approach involves utilizing its proprietary technology platforms to create novel therapeutic candidates and establish partnerships with pharmaceutical and biotechnology firms for clinical development and commercialization. Nektar Therapeutics aims to bring transformative therapies to market that address significant unmet medical needs. More about Nektar Therapeutics's Market Share

Nanoviricides inc Share Performance -24.83% One Year

Nanoviricides inc Profile Nanoviricides Inc. is a pharmaceutical company that operates on a business model based on the development and commercialization of nanomedicines. More about Nanoviricides inc 's Market Share

Novavax inc Share Performance +0.20% This Quarter

Novavax inc Profile Novavax Inc is a biotechnology company focused on the discovery, development, and commercialization of novel vaccines. They aim to leverage their proprietary recombinant nanoparticle vaccine technology platform to address a wide range of infectious diseases. By collaborating with partners and conducting clinical trials, Novavax works towards bringing innovative vaccines to the global market. More about Novavax inc 's Market Share

Sources: Integrated Biopharma Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Sunday, September 6, 2026 6:13 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Integrated Biopharma Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.